Privi Speciality Chemicals Limited (PRIVISCL) Fair Value & Analysis
Basic Materials · IN · Market cap ₹136B
Strengths
Risks
Fair value as of: Aug 23, 2026
From 24 valuation models · updated today
Share price −5.0% over the past month.
A solid business, but screening 59% overvalued on our models.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (₹2,342). The favourable scenario is already priced in.
- The model range is unusually wide (₹848.97 to ₹2,342). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid but not exceptional quality (61/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 23, 2026.
How to read this chart
60‑month range ₹862.70 – ₹3,741 · fair‑value band ₹848.97 – ₹2,342 · the ₹3,478 price screens above the ₹1,421 fair value. Dashed = 300-day average. As of Aug 23, 2026.
Analysis
Privi Speciality Chemicals Limited (PRIVISCL) currently trades at ₹3,478, while our model-based Fair Value estimate is ₹1,421, implying the stock looks roughly 59.2% overvalued today. The Quality Score stands at 61/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Privi Speciality Chemicals Limited generated revenue of ₹26.7B at a net margin of 13.1%. Revenue grew 19.2% year over year. It earns a return on equity of 24.8%. Net debt stands at ₹9.7B. Fundamentals as of Aug 23, 2026
Our scenario range runs from ₹848.97 (bear case) to ₹2,342 (bull case); at ₹3,478, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 8% below its 52-week high and 59% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -67% fair-value upside, at -59%, PRIVISCL screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth Earnings (₹1,801) versus Asset-Based (₹242.26). Highest evidence: Growth DCF (80).
Notify me when PRIVISCL reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 23, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 59 · Market factors (momentum, volatility) 74
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Privi Speciality Chemicals Limited operates as a manufacturer, supplier, and exporter of aroma and fragrance chemicals in India, North America, Asia, the Middle East, Africa, Europe, South America, and the United Kingdom.
Full company description
Privi Speciality Chemicals Limited operates as a manufacturer, supplier, and exporter of aroma and fragrance chemicals in India, North America, Asia, the Middle East, Africa, Europe, South America, and the United Kingdom. The company offers amber fleur, acetates, dihydromyrcenol, ionones, nitriles, sandal wood derivatives, and specialty chemicals, as well as bulk aroma chemicals. It also provides aroma chemicals, including alpha damascone, alpha ionone, alpha terpenyl acetate, amber fleur, amber gamma, beta iso damascol, BI perfumery grade, BI technical grade, carene-60 & Carene-90, cedar ketol, citronellal, citronellyl acetate, citronellyl nitrile, dipentene, double distilled turpentine oil, dihydro myrcenol, dihydromyrcene, gamma methyl ionone, gamma terpenyl acetate, geraniol, geranyl acetate, Indian sandal core, ionone, iso boronyl acetate, l-limonene, methyl ionone, nerol, neryl acetate, nimberol, OTBCHA, pine oil, prionyl, PTBCHA, rose oxide, terpeniol alpha, terpeniol gamma, terpeniol BP grade, terpinolene, and sandal fleur, as well as sandal touch, tetrahydroflorol, tetrahydrogeraniol, tetrahydrogeranyl acetate, tetrahydromyrcenol, timber forte, and timber touch. In addition, the company offers cineol, trimethyl cyclohexyl methanol, cyclamen aldehyde, indomeran, floravane, ambo woody extreme, camphor, and iso berneol commercial. The company was formerly known as Fairchem Speciality Limited and changed its name to Privi Speciality Chemicals Limited in October 2020. Privi Speciality Chemicals Limited was incorporated in 1985 and is based in Mumbai, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Privi Speciality Chemicals Limited reported revenue of ₹25.4B in FY2026 versus ₹14.0B in FY2022, a compound +16.0%/yr. Reported net income was ₹3.3B in FY2026, compounding +35.4%/yr from FY2022.
PRIVISCL screens 59% overvalued. Compare with Linde plc →
Peer Group
Specialty Chemicals · 677 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Chemicals median · lower = cheaper
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 23, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $487.57 | $222.03 | -54% |
| Wanhua Chemical Group 600309 | ¥75.06 | ¥68.03 | -9% |
| Asian Paints Limited ASIANPAINT | ₹2,630 | ₹696.23 | -74% |
| Pidilite Industries Limited PIDILITIND | ₹1,645 | ₹349.83 | -79% |
| Solar Industries India Limited SOLARINDS | ₹18,730 | ₹2,793 | -85% |
| PT Chandra Asri Pacific Tbk TPIA | 2,030 IDR | 2,147 IDR | +6% |
| Berger Paints India Limited BERGEPAINT | ₹541.00 | ₹156.35 | -71% |
| Gujarat Fluorochemicals Limited FLUOROCHEM | ₹4,680 | ₹724.88 | -85% |
| Himadri Speciality Chemical Limited HSCL | ₹703.65 | ₹229.10 | -67% |
| Enaex S.A ENAEX | 25,000 CLP | 23,584 CLP | -6% |
Compare Privi Speciality Chemicals Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Privi Speciality Chemicals Limited (PRIVISCL) overvalued or undervalued?
What is the fair value of PRIVISCL?
What is the quality score of PRIVISCL?
What is the revenue of Privi Speciality Chemicals Limited (PRIVISCL)?
What is the net profit margin of PRIVISCL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Privi Speciality Chemicals Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.